ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Sockit151
|
44 |
10K |
12 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
44
|
10K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Sockit151
|
1.4K |
377K |
7 |
14/07/22 |
14/07/22 |
ASX - By Stock
|
1.4K
|
377K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Sockit151
|
1.4K |
377K |
5 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
1.4K
|
377K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Sockit151
|
1.4K |
377K |
13 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
1.4K
|
377K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: AGM Presentation
|
|
Sockit151
|
74 |
15K |
4 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
74
|
15K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
The Home Stretch
|
|
Sockit151
|
360 |
82K |
4 |
27/10/21 |
27/10/21 |
ASX - By Stock
|
360
|
82K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MPL Manufacturing and Human Trials Update
|
|
Sockit151
|
50 |
9.6K |
3 |
21/10/21 |
21/10/21 |
ASX - By Stock
|
50
|
9.6K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Proposed issue of securities - PAA
|
|
Sockit151
|
164 |
35K |
4 |
13/10/21 |
13/10/21 |
ASX - By Stock
|
164
|
35K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Phase 3 Canines Lymphoma B Trial ( what to expect)
|
|
Sockit151
|
98 |
21K |
3 |
02/09/21 |
02/09/21 |
ASX - By Stock
|
98
|
21K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Oral Treatment for Covid 19, Human Phase I Trials
|
|
Sockit151
|
132 |
28K |
5 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
132
|
28K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Sockit151
|
197 |
35K |
4 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
197
|
35K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Sockit151
|
197 |
35K |
7 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
197
|
35K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Sockit151
|
197 |
35K |
10 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
197
|
35K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Monepantel and monepantel sulfone COVID-19 anti-viral update
|
|
Sockit151
|
74 |
17K |
7 |
26/07/21 |
26/07/21 |
ASX - By Stock
|
74
|
17K
|
7
|
|
ASX - By Stock
|
MFG |
Re:
Tesla and bitcoin prediction
|
|
Sockit151
|
10 |
5.0K |
0 |
22/06/21 |
22/06/21 |
ASX - By Stock
|
10
|
5.0K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Phase IIb Canine Trial Identifies Therapeutic Window for MPL
|
|
Sockit151
|
98 |
18K |
5 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
98
|
18K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Phase IIb Canine Trial Identifies Therapeutic Window for MPL
|
|
Sockit151
|
98 |
18K |
11 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
98
|
18K
|
11
|
|
ASX - By Stock
|
PAA |
VET MAJOR
|
|
Sockit151
|
2 |
617 |
3 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
2
|
617
|
3
|
|
ASX - By Stock
|
PAA |
Re:
HC PAA SH Volume
|
|
Sockit151
|
180 |
40K |
5 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
180
|
40K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Annual Report
|
|
Sockit151
|
61 |
15K |
10 |
21/09/20 |
21/09/20 |
ASX - By Stock
|
61
|
15K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Monepantel Anti-viral Activity Against SARS-CoV-2 Confirmed
|
|
Sockit151
|
134 |
37K |
6 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
134
|
37K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Inhibition of SARS-CoV-2 by MPL in Human Respiratory Cells
|
|
Sockit151
|
139 |
34K |
11 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
139
|
34K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
MPL Verses CV-19 Results : 100% Successful in treating TWO patients In California USA.
|
|
Sockit151
|
335 |
114K |
7 |
18/08/20 |
18/08/20 |
ASX - By Stock
|
335
|
114K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Report delivered under Option Agreement
|
|
Sockit151
|
461 |
92K |
3 |
13/07/20 |
13/07/20 |
ASX - By Stock
|
461
|
92K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
What do we think for the next two weeks
|
|
Sockit151
|
26 |
6.3K |
2 |
13/07/20 |
13/07/20 |
ASX - By Stock
|
26
|
6.3K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
JULY Pharmaust Dual Catalysts
|
|
Sockit151
|
220 |
50K |
13 |
08/07/20 |
08/07/20 |
ASX - By Stock
|
220
|
50K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Shareholder Update
|
|
Sockit151
|
196 |
43K |
10 |
24/06/20 |
24/06/20 |
ASX - By Stock
|
196
|
43K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Confirmation of Preliminary COVID-19 Results
|
|
Sockit151
|
380 |
86K |
4 |
18/06/20 |
18/06/20 |
ASX - By Stock
|
380
|
86K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Dr Richard Mollard - LIVE on Ticker TV Today CV-19 results
|
|
Sockit151
|
20 |
4.1K |
4 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
20
|
4.1K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Voluntary Suspension
|
|
Sockit151
|
356 |
83K |
5 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
356
|
83K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
COULD PHARMAUST HAVE THE ANSWER?
|
|
Sockit151
|
40 |
9.5K |
3 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
40
|
9.5K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Voluntary Suspension
|
|
Sockit151
|
356 |
83K |
5 |
16/06/20 |
16/06/20 |
ASX - By Stock
|
356
|
83K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Voluntary Suspension
|
|
Sockit151
|
356 |
83K |
2 |
16/06/20 |
16/06/20 |
ASX - By Stock
|
356
|
83K
|
2
|
|
ASX - By Stock
|
DJW |
DJW vs AFI
|
|
Sockit151
|
2 |
1.3K |
0 |
11/06/20 |
11/06/20 |
ASX - By Stock
|
2
|
1.3K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Preliminary Positive Results for the Treatment of SARS-CoV-2
|
|
Sockit151
|
285 |
67K |
3 |
04/06/20 |
04/06/20 |
ASX - By Stock
|
285
|
67K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Preliminary Positive Results for the Treatment of SARS-CoV-2
|
|
Sockit151
|
285 |
67K |
9 |
04/06/20 |
04/06/20 |
ASX - By Stock
|
285
|
67K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Preliminary Positive Results for the Treatment of SARS-CoV-2
|
|
Sockit151
|
285 |
67K |
11 |
04/06/20 |
04/06/20 |
ASX - By Stock
|
285
|
67K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
June 3rd , Historic Day for Pharmaust
|
|
Sockit151
|
19 |
7.0K |
15 |
03/06/20 |
03/06/20 |
ASX - By Stock
|
19
|
7.0K
|
15
|
|
ASX - By Stock
|
CGB |
Re:
Ann: Request for extension of voluntary suspension
|
|
Sockit151
|
139 |
64K |
7 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
139
|
64K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
To0p 20 as at 30 April 2020
|
|
Sockit151
|
78 |
21K |
6 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
78
|
21K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Monepantel Trial Achieves Successful Anti-Cancer Outcome
|
|
Sockit151
|
438 |
120K |
15 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
438
|
120K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Tribute to the 402
|
|
Sockit151
|
58 |
13K |
3 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
58
|
13K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Tribute to the 402
|
|
Sockit151
|
58 |
13K |
2 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
58
|
13K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
News: PAA Pharmaust Seeks Trading Halt
|
|
Sockit151
|
4 |
2.0K |
7 |
08/05/20 |
08/05/20 |
ASX - By Stock
|
4
|
2.0K
|
7
|
|